Effect of Low Protein Diet on Top of Dapagliflozin on Chronic Kidney Disease in Patients With Type 2 Diabetes Mellitus

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 200 participants.

Also called NCT06281899

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Anemia Working Group Romania (from the registry)
Registry
  • NCT NCT06281899
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Romania (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06281899. Randomized; no masking; primary purpose treatment. Start 2022-01-01 (actual); primary completion 2027-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effect of Low Protein Diet on Top of Dapagliflozin on Chronic Kidney Disease in Patients With Type 2 Diabetes Mellitus
Acronym
PRODAPA-CKD
Condition
Chronic Kidney Diseases
Condition
Type 2 Diabetes Mellitus
Intervention (Drug)
Dapagliflozin 10 mg Tab
Intervention (Behavioral)
Low protein diet
Lead sponsor
Anemia Working Group Romania (class: other)
Collaborator
Sf Ioan Emergency Clinical Hospital, Nephrology and Dialysis Department, Bucharest, Romania (class: not stated)
Collaborator
Dr Carol Davila Teaching Hospital of Nephrology, Nephrology Department, Bucharest, Romania (class: not stated)
Collaborator
Carol Davila University of Medicine and Pharmacy (class: other)

Record details

Record id
cardio:ct-nct06281899
Content hash
5c8e7e485bcee1ca5cf9e0767526de47de482dac9d60541c8f6aa2a9571e2997